These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 19729434)

  • 1. Mouse models of diabetic nephropathy.
    Brosius FC; Alpers CE; Bottinger EP; Breyer MD; Coffman TM; Gurley SB; Harris RC; Kakoki M; Kretzler M; Leiter EH; Levi M; McIndoe RA; Sharma K; Smithies O; Susztak K; Takahashi N; Takahashi T;
    J Am Soc Nephrol; 2009 Dec; 20(12):2503-12. PubMed ID: 19729434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models of diabetic nephropathy.
    Alpers CE; Hudkins KL
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):278-84. PubMed ID: 21422926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine models of diabetic nephropathy.
    Peters V; Schmitt CP
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):191-3. PubMed ID: 22402945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial nitric oxide synthase.
    Nakagawa T; Johnson RJ
    Contrib Nephrol; 2011; 170():93-101. PubMed ID: 21659762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.
    Takahashi T; Harris RC
    J Diabetes Res; 2014; 2014():590541. PubMed ID: 25371905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism.
    Nakagawa T
    Clin Nephrol; 2009 Feb; 71(2):103-9. PubMed ID: 19203501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decorin deficiency enhances progressive nephropathy in diabetic mice.
    Williams KJ; Qiu G; Usui HK; Dunn SR; McCue P; Bottinger E; Iozzo RV; Sharma K
    Am J Pathol; 2007 Nov; 171(5):1441-50. PubMed ID: 17884968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.
    Kakoki M; Sullivan KA; Backus C; Hayes JM; Oh SS; Hua K; Gasim AM; Tomita H; Grant R; Nossov SB; Kim HS; Jennette JC; Feldman EL; Smithies O
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10190-5. PubMed ID: 20479236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
    Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B
    J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration.
    Merline R; Lazaroski S; Babelova A; Tsalastra-Greul W; Pfeilschifter J; Schluter KD; Gunther A; Iozzo RV; Schaefer RM; Schaefer L
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4(Suppl 4):5-13. PubMed ID: 20083846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?
    Nakhoul F; Nakhoul N; Asleh R; Miller-Lotan R; Levy AP
    Diabetes Res Clin Pract; 2013 Jun; 100(3):289-97. PubMed ID: 23490597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
    Harlan SM; Heinz-Taheny KM; Sullivan JM; Wei T; Baker HE; Jaqua DL; Qi Z; Cramer MS; Shiyanova TL; Breyer MD; Heuer JG
    J Am Soc Nephrol; 2018 Feb; 29(2):477-491. PubMed ID: 29061652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in animal models of diabetic nephropathy.
    Betz B; Conway BR
    Nephron Exp Nephrol; 2014; 126(4):191-5. PubMed ID: 25034792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor.
    Kakoki M; Takahashi N; Jennette JC; Smithies O
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13302-5. PubMed ID: 15326315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link?
    Quaggin SE; Coffman TM
    J Am Soc Nephrol; 2007 Feb; 18(2):364-6. PubMed ID: 17259594
    [No Abstract]   [Full Text] [Related]  

  • 16. Revisiting Experimental Models of Diabetic Nephropathy.
    Giralt-López A; Molina-Van den Bosch M; Vergara A; García-Carro C; Seron D; Jacobs-Cachá C; Soler MJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.
    Zhao HJ; Wang S; Cheng H; Zhang MZ; Takahashi T; Fogo AB; Breyer MD; Harris RC
    J Am Soc Nephrol; 2006 Oct; 17(10):2664-9. PubMed ID: 16971655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Models for Studying Diabetic Nephropathy.
    Chow BSM; Allen TJ
    Curr Protoc Mouse Biol; 2015 Jun; 5(2):85-94. PubMed ID: 26069079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin.
    Schaefer L; Raslik I; Grone HJ; Schonherr E; Macakova K; Ugorcakova J; Budny S; Schaefer RM; Kresse H
    FASEB J; 2001 Mar; 15(3):559-61. PubMed ID: 11259366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
    Kanetsuna Y; Takahashi K; Nagata M; Gannon MA; Breyer MD; Harris RC; Takahashi T
    Am J Pathol; 2007 May; 170(5):1473-84. PubMed ID: 17456755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.